CD68 and neoplasm: After originating from peripheral blood monocytes, macrophages can differentiate into pro-inflammatory CD68+ M1 phenotypes, which have tumoricidal action, promote Th responses and secrete proinflammatory cytokines (TNF-alpha), or CD163+ M2 phenotypes, associated with immunosuppression and tissue repair, facilitating tumor progression [61].